Latest Cover
Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

Adolescent depression reduced after early contact with mental health services

A longitudinal study by Neufield et al published in The Lancet has demonstrated an association between early service contact with mental health services and a...Read more

Ocrelizumab has positive effect against multiple sclerosis.

For the first time a recent phase-three placebo-controlled trial, published in The New England Journal of Medicine, has demonstrated the efficacy of...Read more

Can Alzheimer’s progression be stopped?

New evidence that verubecestat, a small molecule BACE1 inhibitor, reduced beta amyloid plaques in people with Alzheimer’s disease has raised hopes that a...Read more

Anti-inflammatory drugs may improve depression

More evidence that anti-inflammatory drugs may improve some aspects of depression has emerged from a systematic review of anti-cytokine drugs used to treat...Read more

GPs and nurses need more mental health training, says MIND

Only 46 per cent of doctor in GP training in England undertake a placement in a mental health setting, according to the charity MIND. Its survey also found...Read more

Featured Articles

Personalised care in severe mental illness – there’s no need to wait
Repeated promises over several decades from leading academics in imaging and genetics1–3 that biologically personalised treatments were close and would be available in ‘a few years’ have not translated into routine clinical practice. Expansive claims are still made by some, though most contemporary views are …
Click here to view

Treatment for cancer and depression in a female with intellectual disability
Identifying depression in those with an intellectual disability can be difficult as symptoms may differ from those usually observed in the general population. The anti-oestrogen medication tamoxifen is widely used for the treatment of breast cancer and clinically relevant depression may be a common side-effect.
Click here to view

Anorexia nervosa: diagnosis, risk factors and evidence-based treatments
As part of the series on managing neurological and psychiatric conditions in children and adolescents, Dr Sara Kakhi and Dr Jacinta McCann cover recent updates in epidemiology, risk factors, common comorbidities and treatment options for anorexia nervosa.
Click here to view

Web design and marketing agency Leamington Spa